Jun13296

Jun13296 is a potent, orally bioavailable quinoline inhibitor of the SARS-CoV-2 papain-like protease (IC50 = 0.13 μM) . It exhibits broad antiviral activity against variants and resistant mutants, and in vivo studies confirm it reduces lung viral load and mitigates tissue pathology in infection models, supporting its use in coronavirus research.